Clinical study on Herbal Eye drop

Therapeutic Efficacy of Eye Drops prepared by contents of Katakadirasanjan in Visual Display Terminal Vision Syndrome A Clinical Study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/08/035629

Enrollment

Registered

2021-08-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H538- Other visual disturbances

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients between 18 to 40 years of age. 2. Computer users complaining of symptoms like eye strain, blurred vision, headache, redness, burning sensation, irritated dry eyes, slow refocusing and muscle fatigue. 3. Patients having minimum three symptoms of CVS. 4. Patients using computers for minimum 2 to 3 hrs/day and for at least 1 year continuously.

Exclusion criteria

Exclusion criteria: Patients of age below 18 years or above 40 years. 2. Patients not willing to register. 3. Known cases of any systemic or metabolic disorders. 4. Case of chronic or acute infections of eye. 5. Patients having any fundus/retinal pathology like Optic atrophy, Retinal disorder, Papilloedema, etc.

Design outcomes

Primary

Measure	Time frame
Decrease in symptoms like Eye Strain,Blurred Vision,Headache on doing near work,Redness in eyes,Burning Sensation,Muscle Fatigue (Neck/ Shoulder/Back Pain). Approaches to Normal values of Schirmerâ??s Test, Tear Film Break-up TimeTimepoint: 11th, 21st and 31st day	—

Secondary

Measure	Time frame
Effective duration of use of Eye drops, and duration of complete cure of symptoms.Timepoint: 11th, 21st and 31st day	—

Countries

India

Contacts

Public ContactNeeru Sharma

Uttarakhand Ayurved University Rishikul Campus, Haridwar

gunjan06sharma@gmail.com9258030654

Outcome results